SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin’s arm inks agreement to acquire branded product portfolio from Shionogi in Japan

02 Aug 2016 Evaluate

Lupin’s Japanese subsidiary - Kyowa Pharmaceutical Industry Company, has entered into a strategic asset purchase agreement with Shionogi & Company to acquire 21 long-listed products from the Japanese pharma major, effective December 1, 2016, subject to certain closing conditions and regulatory approvals including the transfer of marketing authorization of the products to Kyowa.

As a part of this growth strategy, Shionogi would transfer 21 long-listed products to Kyowa, the Japanese subsidiary of Lupin. Kyowa is amongst the top 10 Generic companies in Japan and a market leader in Central Nervous System (CNS) space well known for its ‘AMEL’ brand, in addition to other generic pharmaceutical products in its portfolio. With this acquisition, Kyowa will rank sixth amongst generic companies in Japan.

The 21 products cover therapy areas such as Central Nervous System (CNS), Oncology, Cardiovascular and Antiinfectives. These 21 products had sales of JPY 9,400 million ($90 million) collectively on National Health Insurance (NHI) price basis.   


Lupin Share Price

2281.00 -96.90 (-4.08%)
11-May-2026 14:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1874.10
Dr. Reddys Lab 1289.65
Cipla 1309.00
Zydus Lifesciences 954.70
Lupin 2281.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×